01 1BioSpectra
01 1TROMETHAMINE
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-07-10
Pay. Date : 2017-06-05
DMF Number : 31483
Submission : 2017-03-21
Status : Active
Type : II
20
Biospectra, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for Manufacturers of Life Science Intermediates, Excipients & APIs for Critical Pharmaceutical Applications.
One of their notable products is TROMETHAMINE, with a corresponding US DMF Number 31483.
Remarkably, this DMF maintains an Active status since its submission on March 21, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 10, 2017, and payment made on June 05, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
